High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.

@article{Wilke2016HighIO,
  title={High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.},
  author={Iris K Wilke and Katrin Witzel and Julia M{\"u}nch and Simon Pecha and Stephan Blankenberg and Hermann C Reichenspurner and Stephan Willems and Monica Patten and Ali Riza Aydin},
  journal={Journal of cardiovascular electrophysiology},
  year={2016},
  volume={27 7},
  pages={
          779-84
        }
}
INTRODUCTION Atrial fibrillation (AF) is an important prognostic parameter in patients with hypertrophic cardiomyopathy (HCM). Though cardiac rhythm management (CRM) devices (e.g., ICD, pacemaker or implantable loop recorder) can detect subclinical AF, data describing the incidence of AF are rare. We therefore investigated the incidence and clinical impact of de novo and subclinical AF detected by CRM devices in patients with HCM. METHODS AND RESULTS In our retrospective single-center study… CONTINUE READING